These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8880075)

  • 1. 5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats.
    Moreau JL; Bös M; Jenck F; Martin JR; Mortas P; Wichmann J
    Eur Neuropsychopharmacol; 1996 Aug; 6(3):169-75. PubMed ID: 8880075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiaversive effects of 5HT2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats.
    Jenck F; Moreau JL; Berendsen HH; Boes M; Broekkamp CL; Martin JR; Wichmann J; Van Delft AM
    Eur Neuropsychopharmacol; 1998 Aug; 8(3):161-8. PubMed ID: 9716307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curative effects of the atypical antidepressant mianserin in the chronic mild stress-induced anhedonia model of depression.
    Moreau JL; Bourson A; Jenck F; Martin JR; Mortas P
    J Psychiatry Neurosci; 1994 Jan; 19(1):51-6. PubMed ID: 8148366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the 5-HT(6) receptor agonist ST 1936 on depression- and anhedonia-like experimental models.
    Scheggi S; Marchese G; Borsini F; Bordi F; De Montis MG
    Behav Brain Res; 2011 Oct; 224(1):35-43. PubMed ID: 21645553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolcapone: a potential new antidepressant detected in a novel animal model of depression.
    Moreau JL; Borgulya J; Jenck F; Martin JR
    Behav Pharmacol; 1994 Jun; 5(3):344-350. PubMed ID: 11224284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety.
    Kennett G; Lightowler S; Trail B; Bright F; Bromidge S
    Eur J Pharmacol; 2000 Jan; 387(2):197-204. PubMed ID: 10650160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression.
    Przegaliński E; Moryl E; Papp M
    Neuropharmacology; 1995 Oct; 34(10):1305-10. PubMed ID: 8570028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206,553.
    Millan MJ; Girardon S; Bervoets K
    Neuropharmacology; 1997; 36(4-5):743-5. PubMed ID: 9225301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO 60-0175: a pharmacological analysis.
    Dekeyne A; Girardon S; Millan MJ
    Neuropharmacology; 1999 Mar; 38(3):415-23. PubMed ID: 10219979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesolimbic dopamine system and its modulation by vitamin D in a chronic mild stress model of depression in the rat.
    Sedaghat K; Yousefian Z; Vafaei AA; Rashidy-Pour A; Parsaei H; Khaleghian A; Choobdar S
    Behav Brain Res; 2019 Jan; 356():156-169. PubMed ID: 30144460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT2C receptor agonists attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
    Nakai K; Nakae A; Oba S; Mashimo T; Ueda K
    Eur J Pain; 2010 Nov; 14(10):999-1006. PubMed ID: 20488736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfunctionality of serotonin-2C receptor-mediated inhibition of accumbal dopamine release in an animal model of depression is reversed by antidepressant treatment.
    Dremencov E; Newman ME; Kinor N; Blatman-Jan G; Schindler CJ; Overstreet DH; Yadid G
    Neuropharmacology; 2005 Jan; 48(1):34-42. PubMed ID: 15617725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment.
    Moreau JL; Scherschlicht R; Jenck F; Martin JR
    Behav Pharmacol; 1995 Nov; 6(7):682-687. PubMed ID: 11224370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT2C receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment.
    Mongeau R; Martin CB; Chevarin C; Maldonado R; Hamon M; Robledo P; Lanfumey L
    J Neurochem; 2010 Oct; 115(2):438-49. PubMed ID: 20796171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmentum self-stimulation behavior in rats.
    Moreau JL; Jenck F; Martin JR; Mortas P; Haefely WE
    Eur Neuropsychopharmacol; 1992 Mar; 2(1):43-9. PubMed ID: 1638173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine evidence that (S)-2-(chloro-5-fluoro-indol- l-yl)-1-methylethylamine fumarate (Ro 60-0175) is not a selective 5-hydroxytryptamine(2C) receptor agonist.
    Damjanoska KJ; Muma NA; Zhang Y; D'Souza DN; Garcia F; Carrasco GA; Kindel GH; Haskins KA; Shankaran M; Petersen BR; Van De Kar LD
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1209-16. PubMed ID: 12604698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat.
    Clifton PG; Lee MD; Dourish CT
    Psychopharmacology (Berl); 2000 Oct; 152(3):256-67. PubMed ID: 11105935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo.
    Millan MJ; Dekeyne A; Gobert A
    Neuropharmacology; 1998 Jul; 37(7):953-5. PubMed ID: 9776391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.